Darned Israelis make it so inconvenient to launch and effective boycott.
The latest example of the creative energy and innovation of Israel that has the BDS'ers gnashing their teeth is MedinIsrael, scheduled next month in Tel Aviv.
Representatives from over 60 countries around the world will gather in Tel Aviv March 23rd -26th in a conference that will introduce the latest life-saving Israeli medical innovations.
More than 120 Israeli medical device and health information technology companies will be participating in the conference.
Profiled are
* B-Cure Laser, the world’s first portable/home use Low Level Laser Therapy (LLLT) pain treatment device,
* BioGaming, an Israeli start-up that has won 1st prize Innovation Award at Medica 2014, which develops virtual reality computer games for orthopedics and sports rehabilitation
*EnzySurge, with products designed to treat chronic wounds and promote long-term natural healing processes.
*Doctome, an accessible, affordable telemedicine service which allows people around the globe to consult a caregiver in their own language by video and chat,
*Biovo Technologies, which has engineered groundbreaking ventilation devices for surgical patients
* Epsilor, a manufacturer of custom medical battery packs and charger solutions for emergency, surgical, therapeutic, and other healthcare applications.
*Integrity Applications, which has developed a non-invasive blood glucose
monitor
For more information, check out the MedinIsrael conference webpage
Showing posts with label Israel innovation. Show all posts
Showing posts with label Israel innovation. Show all posts
Saturday, February 7, 2015
Tuesday, February 2, 2010
A New Product to Boycott: Non-invasive lung cancer test developed in Israel.
Another medical marvel out of Israel- A non-invasive, inexpensive way to diagnose lung cancer:
"Using an array of sensors made of gold particles measuring just 5-nanometers wide (one nanometer is 1/100,000 the width of a human hair), researchers at the Technion-Israel Institute of Technology have developed an "electronic nose" able to distinguish the breath of lung cancer patients from those without the disease. The research results, published online yesterday on the Website of Nature Nanotechnology, could lead to a rapid and non-invasive way of diagnosing and screening for lung cancer." In an initial trial, the “breathalyzer” test was able to detect lung cancer with 86 percent accuracy.
Also interesting about this project is that the research in Israel was led by Dr. Hossam Haick, an Arab Israeli and winner of many awards for his research, including the Chair for Leaders in Science and Technology (2006-2008), the Israel-France Award for Academic Excellence (2008), the Herschel Rich Innovation Award (2008), the Minerva Short-Term Research Award (2008), the Bergmann Award for Excellent Young Scientists (2007), the CREATE Award (2007), the Al-Qendil Prize (2007), and the YMCA (2007) and Rotary (2007) Honorary Decorations. In addition, Dr. Haick was selected for the lists of “50 Leading Israelis for 2007” and “four saluted Israeli scientists” of Yedioth Aharonot. Other honors and awards include the Fulbright fellowship, ‘Israel Ministry of Science and Technology' awards, Dr. Avrahami prize, and CNR-IMIP prize. Just what we'd expect from Israel, the apartheid state.
These findings have great potential for fast, easy, and cost-effective early diagnosis and screening of lung cancer. Be sure to look for this, and other fine Israeli innovations on the next Code Pink boycott list, because saving lives is never as important as advancing an ideology.
"Using an array of sensors made of gold particles measuring just 5-nanometers wide (one nanometer is 1/100,000 the width of a human hair), researchers at the Technion-Israel Institute of Technology have developed an "electronic nose" able to distinguish the breath of lung cancer patients from those without the disease. The research results, published online yesterday on the Website of Nature Nanotechnology, could lead to a rapid and non-invasive way of diagnosing and screening for lung cancer." In an initial trial, the “breathalyzer” test was able to detect lung cancer with 86 percent accuracy.
Also interesting about this project is that the research in Israel was led by Dr. Hossam Haick, an Arab Israeli and winner of many awards for his research, including the Chair for Leaders in Science and Technology (2006-2008), the Israel-France Award for Academic Excellence (2008), the Herschel Rich Innovation Award (2008), the Minerva Short-Term Research Award (2008), the Bergmann Award for Excellent Young Scientists (2007), the CREATE Award (2007), the Al-Qendil Prize (2007), and the YMCA (2007) and Rotary (2007) Honorary Decorations. In addition, Dr. Haick was selected for the lists of “50 Leading Israelis for 2007” and “four saluted Israeli scientists” of Yedioth Aharonot. Other honors and awards include the Fulbright fellowship, ‘Israel Ministry of Science and Technology' awards, Dr. Avrahami prize, and CNR-IMIP prize. Just what we'd expect from Israel, the apartheid state.
These findings have great potential for fast, easy, and cost-effective early diagnosis and screening of lung cancer. Be sure to look for this, and other fine Israeli innovations on the next Code Pink boycott list, because saving lives is never as important as advancing an ideology.
Subscribe to:
Posts (Atom)